Type to search

Pfizer Announces Start of Phase 3 Clinical Trial in Adults for its Investigational Vaccine Against Respiratory Syncytial Virus (RSV) | Pharmtech Focus
NuvoAir Respiratory Platform Shows Promise for Long-Term Remote Monitoring of Asthma | Pharmtech Focus
Rising Demand for Needle-free Vaccines to Drive Innovation in the Respiratory Virus Vaccines Market | Pharmtech Focus